-
Nonivamide: A TRPV1 Receptor Agonist Transforming Cancer ...
2025-10-22
Nonivamide, a capsaicin analog and selective TRPV1 receptor agonist, is redefining anti-proliferative strategies in cancer research by enabling precise mitochondrial apoptosis induction and robust neuroimmune modulation. This article details optimized experimental workflows, advanced applications in glioma and SCLC models, and practical troubleshooting tips for maximizing outcomes with Nonivamide.
-
CA-074 Me: Unraveling Cathepsin B Inhibition in Necroptos...
2025-10-21
Explore how CA-074 Me, a potent cathepsin B inhibitor, enables advanced dissection of necroptosis and lysosomal protease signaling. This in-depth analysis connects recent mechanistic discoveries with innovative experimental strategies, offering fresh insights for apoptosis and inflammation research.